Alins.Pa
ALINS.PA provides advanced medical equipment and technology solutions, primarily generating revenue through the sale and servicing of diagnostic imaging systems and related healthcare technologies.
Business. ALINS.PA provides advanced medical equipment and technology solutions, primarily generating revenue through the sale and servicing of diagnostic imaging systems and related healthcare technologies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ALINS.PA provides advanced medical equipment and technology solutions, primarily generating revenue through the sale and servicing of diagnostic imaging systems and related healthcare technologies.
The company's capital structure is highly leveraged, with a debt-to-equity ratio of -1.36, indicating that liabilities significantly exceed equity. Liquidity is constrained, as evidenced by a current ratio of 0.87, and the firm holds only 797,460 EUR in cash and equivalents, which is insufficient to cover its long-term debt of 9,304,120 EUR. This suggests a high dependency on external financing to meet obligations.
Profitability is severely challenged, with a net loss of 10,809,110 EUR and an operating loss of 10,679,690 EUR, resulting in a negative return on assets of -1.35%. The return on equity is also negative at 1.58%, which is far below the typical performance metrics for the industry. These figures indicate that the company is not generating sufficient returns to justify its capital structure.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification increases the company's exposure to market-specific risks and could limit its ability to grow through new markets or product lines.
The company's growth trajectory is negative, with a reported revenue of 2,963,330 EUR and a net loss of 10,809,110 EUR. Analysts have noted a last actual EPS of -0.07 EUR and a revenue of 3,305,000,000 EUR, which suggests a challenging outlook for the company's earnings and revenue growth. The company's financial performance indicates a need for strategic adjustments to improve profitability and reduce losses.
The company faces significant financial risks, including a high liquidity risk due to its negative net cash position and a medium risk of dilution, although the probability is currently low. The company's financial snapshot indicates that it may need to issue additional shares or take on more debt to fund operations, which could dilute existing shareholders' equity. The risk assessment highlights the need for the company to address its liquidity and capital structure issues to avoid further financial distress.
Recent events, as reflected in the company's financial filings, show a continued decline in profitability and an increase in debt levels. The company's management has not disclosed any significant strategic initiatives or cost-cutting measures that could reverse the current financial trajectory. The lack of positive developments in the company's financial performance raises concerns about its long-term viability and the potential for further losses.
- The company is experiencing significant financial distress, with a net loss and a negative return on assets.
- Liquidity is constrained, with a current ratio below 1 and insufficient cash to cover long-term debt.
- The company's profitability is severely challenged, with a negative return on equity and operating losses.
- There is a lack of geographic and segment diversification, increasing exposure to market-specific risks.
- The company's growth trajectory is negative, with a need for strategic adjustments to improve financial performance.
- **margin_outlook_rationale**: The company's operating margin is expected to remain negative due to ongoing losses and high debt servicing costs.
- **rd_outlook_rationale**: There is no specific information provided on R&D spending or future product development plans.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Assetsnet_income / total_assets
- ALINS.PA Market data — financials · 2026-05-27
- Intrasense SA Market data — analyst estimates · 2026-05-27